Increased spontaneous mutation frequency in human cells expressing the phage PBS2-encoded inhibitor of uracil-DNA glycosylase

Mutation Research - DNA Repair

Volumn 461, Issue 1, 2000, Pages 41-58

  Radany, Eric H ^a   Dornfeld, Kenneth J ^b   Sanderson, Russell J ^c   Savage, Melanie K ^c   Majumdar, Alokes ^d   Seidman, Michael M ^d   Mosbaugh, Dale W ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Mutator phenotype; Ugi protein; Ung mutant; Uracil DNA glycosylase

Indexed keywords

URACIL DNA GLYCOSYLTRANSFERASE;

ARTICLE; BASE MISPAIRING; COMPLEX FORMATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPONTANEOUS MUTATION;

BACILLUS PHAGES; CELL CYCLE; DNA GLYCOSYLASES; DNA REPAIR; ENZYME INHIBITORS; GENETIC VECTORS; GLIOMA; HUMANS; MUTAGENESIS; N-GLYCOSYL HYDROLASES; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; URACIL-DNA GLYCOSIDASE; VIRAL PROTEINS;

EID: 0034665836     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(00)00040-9     Document Type: Article

References (67)

1. Lindahl T., Wood R.D. Quality control by DNA repair. Science. 286:1999;1897-1905.
2. Krokan H.E., Standal R., Slupphaug G. DNA glycosylases in the base excision repair of DNA. Biochem. J. 325:1997;1-16.
3. Mosbaugh D.W., Bennett S.E. Uracil-excision DNA repair. Prog. Nucleic Acid Res. Mol. Biol. 48:1994;315-370.
4. Duncan B.K., Miller J.H. Mutagenic deamination of cytosine residues in DNA. Nature. 287:1980;560-561.
5. Duncan B.K., Weiss B. Specific mutator effects of ung (uracil-DNA glycosylase) mutations in Escherichia coli. J. Bacteriol. 151:1982;750-755.
6. Impellizzeri K.J., Anderson B., Burgers P.M.J. The spectrum of spontaneous mutations in a Saccharomyces cerevisiae uracil-DNA-glycosylase mutant limits the function of this enzyme to cytosine deamination repair. J. Bacteriol. 173:1991;6807-6810.
7. Olsen L.C., Aasland R., Wittwer C.U., Krokan H.E., Helland D.E. Molecular cloning of human uracil-DNA glycosylase, a highly conserved DNA repair enzyme. EMBO J. 8:1989;3121-3125.
8. Upton C., Stuart D.T., McFadden G. Identification of a poxvirus gene encoding a viral uracil DNA glycosylase. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4518-4522.
9. Fortini P., Pascucci B., Parlanti E., Sobol R.W., Wilson S.W., Dogliotti E. Different DNA polymerases are involved in the short-and long-patch base excision repair in mammalian cells. Biochemistry. 37:1998;3575-3580.
10. Frosina G., Fortini P., Rossi O., Carrozzino F., Raspaglio G., Cox L.S., Land D.P., Abbondandolo A., Dogliotti E. Two pathways for base excision repair in mammalian cells. J. Biol. Chem. 271:1996;9573-9578.
11. Klungland A., Lindahl T. Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1). EMBO J. 16:1997;3341-3348.
12. Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18:1998;6538-6547.
13. Neddermann P., Jiricny J. Efficient removal of uracil from G:U mispairs by the mismatch-specific thymine DNA glycosylase from HeLa cells. Proc. Natl. Acad. Sci. U.S.A. 91:1994;1642-1646.
14. Muller S., Caradonna S. Cell cycle regulation of a human cyclin-like gene encoding uracil-DNA glycosylase. J. Biol. Chem. 268:1993;1310-1319.
15. r 36,000 phosphoprotein. J. Biol. Chem. 273:1998;21909-21917.
16. Nilsen H., Otterlei M., Haug T., Solum K., Nagelhus T.A., Skorpen F., Krokan H.E. Nuclear and mitochondrial uracil-DNA glycosylase are generated by alternative splicing and transcription from different positions in the UNG gene. Nucleic Acids Res. 25:1997;750-755.
17. Caradonna S., Ladner R., Hansbury M., Kosciuk M., Lynch F., Muller S. Affinity purification and comparative analysis of two distinct human uracil-DNA glycosylases. Exp. Cell Res. 222:1996;345-359.
18. Hendrich B., Hardeland U., Ng H.H., Jiricny J., Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature. 401:1999;301-304.
19. Putnam C.D., Shroyer M.J., Lundquist A.J., Mol C.D., Arvai A.S., Mosbaugh D.W., Tainer J.A. Protein mimicry of DNA from crystal structures of the uracil-DNA glycosylase inhibitor protein and its complex with Escherichia coli uracil-DNA glycosylase. J. Mol. Biol. 287:1999;331-346.
20. Haushalter K.A., Stukenberg P.T., Kirschner M.W., Verdine G.L. Identification of a new uracil-DNA glycosylase family by expression cloning using synthetic inhibitors. Curr. Biol. 9:1999;174-185.
21. Bennett S.E., Mosbaugh D.W. Characterization of the Escherichia coli uracil-DNA glycosylase·inhibitor protein complex. J. Biol. Chem. 267:1992;22512-22521.
22. Bennett S.E., Schimerlik M.I., Mosbaugh D.W. Kinetics of the uracil-DNA glycosylase/inhibitor protein association. J. Biol. Chem. 268:1993;26879-26885.
23. Sanderson R.J., Mosbaugh D.W. Identification of specific carboxyl groups on uracil-DNA glycosylase inhibitor protein that are required for activity. J. Biol. Chem. 271:1996;29170-29181.
24. Wang Z., Mosbaugh D.W. Uracil-DNA glycosylase inhibitor gene of bacteriophage PBS2 encodes a binding protein specific for uracil-DNA glycosylase. J. Biol. Chem. 264:1989;1163-1171.
25. Cone R., Bonura T., Friedberg E.C. Inhibitor of uracil-DNA glycosylase induced by bacteriophage PBS2. J. Biol. Chem. 255:1980;10354-10358.
26. Winters T.A., Williams M.V. Use of the PBS2 uracil-DNA glycosylase inhibitor to differentiate the uracil-DNA glycosylase activity encoded by herpes simplex virus types 1 and 2. J. Virol. Methods. 29:1990;233-242.
27. Mol C.D., Arvai A.S., Sanderson R.J., Slupphaug G., Kavli B., Krokan H.E., Mosbaugh D.W., Tainer J.A. Crystal structure of human uracil-DNA glycosylase in complex with a protein inhibitor: protein mimicry of DNA. Cell. 82:1995;701-708.
28. Sanderson R.J., Mosbaugh D.W. Fidelity and mutational specificity of uracil-initiated base excision DNA repair synthesis in human glioblastoma cell extracts. J. Biol. Chem. 273:1998;24822-24831.
29. Reddy S.M., Williams M., Cohen J.I. Expression of a uracil DNA glycosylase (UNG) inhibitor in mammalian cells: Varicella-Zoster virus can replicate in vitro in the absence of detectable UNG activity. Virology. 251:1998;393-401.
30. Bigner D.D., Bigner S.H., Ponten J., Westermark B., Ruoslahti M.S.E., Herschman H., Eng L.F., Wikstrand C.J., Mahley M.S. Jr. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol. 40:1981;201-229.
31. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor, New York, 1989.
32. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U.S.A. 18:1993;8392-8396.
33. J.H. Miller, A Short Course in Bacterial Genetics: A Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor, New York, 1992, pp. 263-274.
34. Hochhauser S.J., Weiss B. Escherichia coli mutants deficient in deoxyuridine triphosphatase. J. Bacteriol. 134:1978;157-166.
35. Hsieh C.-L., McCloskey R.P., Radany E., Lieber M.R. V(D)J Recombination: evidence that a replicative mechanism is not required. Mol. Cell. Biol. 11:1991;3972-3977.
36. Seidman M.M., Dixon K., Razzaque A., Zagursky R.J., Berman M.L. A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells. Gene. 38:1985;233-237.
37. Bennett S.E., Sanderson R.J., Mosbaugh D.W. Processivity of Escherichia coli and rat liver mitochondrial uracil-DNA glycosylase is affected by NaCl concentration. Biochemistry. 34:1995;109-6119.
38. Longley M.J., Mosbaugh D.W. In situ detection of DNA-metabolizing enzymes following polyacrylamide gel electrophoresis. Methods Enzymol. 218:1993;587-609.
39. Wang Z., Smith D.G., Mosbaugh D.W. Overproduction and characterization of the uracil-DNA glycosylase inhibitor of bacteriophage PBS2. Gene. 99:1991;31-37.
40. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell Biol. 115:1991;887-903.
41. Miller A.D., Rosman G.J. Improved retroviral vectors for gene transfer and expression. BioTechniques. 7:1989;980-982.
42. Boshart M., Weber F., Hahn G., Dorsch-Hsler K., Fleckenstein B., Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell. 41:1985;521-530.
43. Macejak D.G., Sarnow P. Internal initiation of translation mediated by the 5′ leader of a cellular mRNA. Nature. 353:1991;90-94.
44. Yenofsky R.L., Fine M., Pellow J.W. A mutant neomycin phosphotransferase II gene reduces the resistance of transformants to antibiotic selection pressure. Proc. Natl. Acad. Sci. U.S.A. 87:1990;3435-3439.
45. Woods-Ignatoski K.M., Lapointe A.J., Radany E.H., Ethier S.P. ErbB-2 overexpression in human mammary epithelial cells confers growth factor independence. Endocrinology. 140:1999;1-8.
46. Parris C.N., Seidman M.M. A signature element distinguishes sibling and independent mutations in a shuttle vector plasmid. Gene. 117:1992;1-5.
47. Bernard H.-U., Krammer G., Rowenkamp W.G. Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. Exp. Cell Res. 158:1985;237-243.
48. Schmeissner U., Ganem D., Miller J.H. Genetic studies of the lac repressor II: fine structure deletion map of the lacI gene and its correlation with the physical map. J. Mol. Biol. 109:1977;303-326.
49. Neumann C.M., Oughton J.A., Kerkvliet N.I. Anti-CD3-induced T-cell activation-II: effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Int. J. Immunopharmacol. 15:1993;543-550.
50. Kraemer K.H., Seidman M.M. Use of supF, an Escherichia coli tyrosine suppressor tRNA gene, as a mutagenic target in shuttle-vector plasmids. Mut. Res. 220:1989;61-72.
51. Razzaque A., Mizusawa H., Seidman M.M. Rearrangement and mutagenesis of a shuttle vector plasmid after passage in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 80:1983;3010-3014.
52. Singhal R.K., Prasad R., Wilson S.W. DNA polymerase beta conducts the gap-filling step in uracil-initiated base excision repair in a bovine testis nuclear extract. J. Biol. Chem. 270:1995;949-957.
53. Ullah S., Gallinari P., Xu Y-Z., Goodman M.F., Bloom L.B., Jiricny J., Day III R.S. Base analog and neighboring base effects on substrate specificity of recombinant human G:T mismatch-specific thymine DNA-glycosylase. Biochemistry. 35:1996;12926-12932.
54. Haug T., Skorpen F., Aas P.A., Malm V., Skjelbred C., Krokan H.E. Regulation of expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase. Nucleic Acids Res. 26:1998;1449-1457.
55. Nagelhus T.A., Slupphaug G., Lindmo T., Krokan H.E. Cell cycle regulation and subcellular localization of the major human uracil-DNA glycosylase. Exp. Cell Res. 220:1995;292-297.
56. Walsh M.J., Shue G., Spidoni K., Kapoor A. E2F-1 and a cyclin-like DNA repair enzyme, uracil-DNA glycosylase, provide evidence for an autoregulatory mechanism for transcription. J. Biol. Chem. 270:1995;5289-5298.
57. Burgers P.M.J., Klein M.B. Selection by genetic transformation of a Saccharomyces cerevisiae mutant defective for the nuclear uracil-DNA-glycosylase. J. Bacteriol. 166:1986;905-913.
58. Duncan B.K. Isolation of insertion, deletion, and nonsense mutations of the uracil-DNA glycosylase (ung) gene of Escherichia coli K-12. J. Bacteriol. 164:1985;689-695.
59. Wang Z., Mosbaugh D.W. Uracil-DNA glycosylase inhibitor of bacteriophage PBS2: cloning and effects of expression of the inhibitor gene in Escherichia coli. J. Bacteriol. 170:1988;1082-1091.
60. Millns A.K., Carpenter M.S., DeLange A.M. The vaccinia virus-encoded uracil DNA glycosylase has a essential role in viral DNA replication. Virology. 198:1994;504-513.
61. Prichard M.N., Duke G.M., Mocarski E.S. Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J. Virol. 70:1996;3018-3025.
62. Stuart D.T., Upton C., Higman M.A., Niles E.G., McFadden G. A poxvirus-encoded uracil DNA glycosylase is essential for virus viability. J. Virol. 67:1993;2503-2512.
63. Muller-Weeks S.J., Caradonna S. Specific association of cyclin-like uracil-DNA glycosylase with the proliferating cell nuclear antigen. Exp. Cell Res. 226:1996;346-355.
64. Nagelhus T.A., Haug T., Singh K.K., Keshav K.F., Skorpen F., Otterlei M., Bharati S., Lindmo T., Benichou S., Benarous R., Krokan H.E. A sequence in the N-terminal region of human uracil-DNA glycosylase with homology to XPA interacts with the C-terminal part of the 34-kDa subunit of replication protein A. J. Biol. Chem. 272:1997;6561-6566.
65. Otterlei M., Warbrick E., Nagelhus T.A., Haug T., Slupphaug G., Akbari M., Aas P.A., Steinsbekk K., Bakke O., Krokan H.E. Post-replicative base excision repair in replication foci. EMBO J. 18:1999;3834-3844.
66. 4-ethenocytosine, a highly mutagenic adduct, is a primary substrate for Escherichia coli double-stranded uracil-DNA glycosylase and human mismatch-specific thymine-DNA glycosylase. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8508-8513.
67. Waters T.R., Swann P.F. Kinetics of the action of thymine DNA glycosylase. J. Biol. Chem. 273:1998;20007-20014.